Full text is available at the source.
Abstract
Recent trials in advanced cancer populations report improvements in anxiety, depression, pain-related distress, and quality of life following one or two dosing sessions of psychedelic-assisted therapy.
- Psychedelic-assisted therapy (PAT) combines psychedelic compounds with structured psychotherapeutic support.
- PAT may enhance neuroplasticity and emotional flexibility, potentially supporting sustained psychological change.
- Current evidence on PAT is limited by small sample sizes and narrow demographic representation.
- Variable treatment protocols and potential expectancy effects could influence observed outcomes.
- Practical challenges in implementation include the need for specialized training and resource intensity.
Simplified